PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RXO vs. SNDR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RXO and SNDR is 0.50, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.5

Performance

RXO vs. SNDR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RXO Inc. (RXO) and Schneider National, Inc. (SNDR). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%20.00%SeptemberOctoberNovemberDecember2025February
-31.87%
0.66%
RXO
SNDR

Key characteristics

Sharpe Ratio

RXO:

-0.08

SNDR:

0.69

Sortino Ratio

RXO:

0.25

SNDR:

1.12

Omega Ratio

RXO:

1.03

SNDR:

1.13

Calmar Ratio

RXO:

-0.10

SNDR:

0.53

Martin Ratio

RXO:

-0.28

SNDR:

2.43

Ulcer Index

RXO:

13.78%

SNDR:

7.32%

Daily Std Dev

RXO:

49.33%

SNDR:

25.72%

Max Drawdown

RXO:

-37.74%

SNDR:

-44.03%

Current Drawdown

RXO:

-36.87%

SNDR:

-18.59%

Fundamentals

Market Cap

RXO:

$3.27B

SNDR:

$4.78B

EPS

RXO:

-$2.14

SNDR:

$0.66

PEG Ratio

RXO:

4.36

SNDR:

4.35

Total Revenue (TTM)

RXO:

$2.88B

SNDR:

$5.29B

Gross Profit (TTM)

RXO:

$573.67M

SNDR:

$735.10M

EBITDA (TTM)

RXO:

$29.58M

SNDR:

$582.50M

Returns By Period

In the year-to-date period, RXO achieves a -15.52% return, which is significantly lower than SNDR's -6.83% return.


RXO

YTD

-15.52%

1M

-23.10%

6M

-31.87%

1Y

-6.15%

5Y*

N/A

10Y*

N/A

SNDR

YTD

-6.83%

1M

-8.46%

6M

0.65%

1Y

16.15%

5Y*

9.06%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RXO vs. SNDR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RXO
The Risk-Adjusted Performance Rank of RXO is 4040
Overall Rank
The Sharpe Ratio Rank of RXO is 4242
Sharpe Ratio Rank
The Sortino Ratio Rank of RXO is 3939
Sortino Ratio Rank
The Omega Ratio Rank of RXO is 3939
Omega Ratio Rank
The Calmar Ratio Rank of RXO is 4040
Calmar Ratio Rank
The Martin Ratio Rank of RXO is 4141
Martin Ratio Rank

SNDR
The Risk-Adjusted Performance Rank of SNDR is 6666
Overall Rank
The Sharpe Ratio Rank of SNDR is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of SNDR is 6262
Sortino Ratio Rank
The Omega Ratio Rank of SNDR is 5959
Omega Ratio Rank
The Calmar Ratio Rank of SNDR is 6969
Calmar Ratio Rank
The Martin Ratio Rank of SNDR is 7070
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RXO vs. SNDR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for RXO Inc. (RXO) and Schneider National, Inc. (SNDR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RXO, currently valued at -0.08, compared to the broader market-2.000.002.00-0.080.69
The chart of Sortino ratio for RXO, currently valued at 0.25, compared to the broader market-4.00-2.000.002.004.006.000.251.12
The chart of Omega ratio for RXO, currently valued at 1.03, compared to the broader market0.501.001.502.001.031.13
The chart of Calmar ratio for RXO, currently valued at -0.10, compared to the broader market0.002.004.006.00-0.100.53
The chart of Martin ratio for RXO, currently valued at -0.28, compared to the broader market-10.000.0010.0020.0030.00-0.282.43
RXO
SNDR

The current RXO Sharpe Ratio is -0.08, which is lower than the SNDR Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of RXO and SNDR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.000.501.001.502.00SeptemberOctoberNovemberDecember2025February
-0.08
0.69
RXO
SNDR

Dividends

RXO vs. SNDR - Dividend Comparison

RXO has not paid dividends to shareholders, while SNDR's dividend yield for the trailing twelve months is around 1.39%.


TTM20242023202220212020201920182017
RXO
RXO Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SNDR
Schneider National, Inc.
1.39%1.30%1.41%1.37%1.04%10.92%1.10%1.29%0.53%

Drawdowns

RXO vs. SNDR - Drawdown Comparison

The maximum RXO drawdown since its inception was -37.74%, smaller than the maximum SNDR drawdown of -44.03%. Use the drawdown chart below to compare losses from any high point for RXO and SNDR. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%SeptemberOctoberNovemberDecember2025February
-36.87%
-18.59%
RXO
SNDR

Volatility

RXO vs. SNDR - Volatility Comparison

RXO Inc. (RXO) has a higher volatility of 21.25% compared to Schneider National, Inc. (SNDR) at 6.15%. This indicates that RXO's price experiences larger fluctuations and is considered to be riskier than SNDR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
21.25%
6.15%
RXO
SNDR

Financials

RXO vs. SNDR - Financials Comparison

This section allows you to compare key financial metrics between RXO Inc. and Schneider National, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab